AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 37 filers reported holding AXSOME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $514,000 | +81.0% | 19,958 | 0.0% | 0.10% | +108.7% |
| Q1 2019 | $284,000 | +407.1% | 19,958 | 0.0% | 0.05% | +360.0% |
| Q4 2018 | $56,000 | -18.8% | 19,958 | 0.0% | 0.01% | -9.1% |
| Q3 2018 | $69,000 | +7.8% | 19,958 | 0.0% | 0.01% | +10.0% |
| Q2 2018 | $64,000 | +30.6% | 19,958 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $49,000 | -56.2% | 19,958 | 0.0% | 0.01% | -52.9% |
| Q4 2017 | $112,000 | – | 19,958 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |